FN1 and hepatocellular carcinoma: Immunofluorescence analysis revealed that the expression of FN1 in the Sch B-treated group was lower than that in the control group (Figure 6E), and the same results were obtained in the Western blotting test (Figure 6F), suggesting that Sch B may inhibit the growth of HCC by inhibiting the expression of FN1.